Let’s Make the Fight Against Kidney Cancer Personal
Did you know your immune system has the ability to fight cancer? It just needs to be shown how! Newer types of immunotherapy are being developed to do just that.
AGS-003 is a new type of personalized immunotherapy that is being evaluated in a phase 3 clinical study called ADAPT for the treatment of advanced kidney cancer.Learn more about AGS-003 and the ADAPT trial from the experts